Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Reaction Biology opens protein production facility
The company has also expanded its available list of methyltransferase and related proteins to 27. RBC chief technology officer Haiching Ma said, "The new facility expands our space
The company has also expanded its available list of methyltransferase and related proteins to 27. RBC chief technology officer Haiching Ma said, "The new facility expands our space
The injectable, sustained-release intravitreal insert releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic DME. pSivida president and chief executive
The supplement, New Life Naturals: For Her Senses, is intended to help the American women suffering with female sexual dysfunction (FSD). Nouveau has opted to partner with an
The synthetic vasopressin analogue acts through the vasopressin V1 receptor as a systemic vasoconstrictor, primarily in the splanchnic (abdominal) circulation. Thus effective arterial volume increases and renal blood
The Nagpur facility is intended to export formulations to developed markets like US, Europe, Japan and along with other key emerging markets. The new formulation plant is expected
LE-Poly ICLC is an antiviral agent proven to be effective in animal studies against avian influenza virus, ebola and alphavirus infections. Under a sub-contract from Oncovir, Dalton established
The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. The dashboard utilizes content from Thomson Reuters
Under the agreement, ProMetic will receive $1.4m and the client will be provided with a biosimilar product. PBL chief executive officer Steve Burton said the company’s technology allows
The production process is an environmentally friendly and indicates the potential for improving the overall increase in yield of sitagliptin, while decreasing waste byproducts, Codexis said. Codexis interim
The products include JHP-Rodler, Betadorm D, Rhinopront, Collomack Topical, Tirgon and Xitix. Recordati chairman and CEO Giovanni Recordati said, "The OTC pharmaceutical segment in Germany is worth around